Cohort

When the data as a whole are reviewed for studies on humans exposed to ethylene oxide, no conclusion can be made that there is an increase in mortahty associated with those exposed to ethylene oxide. Two Swedish studies (247,248) indicated an increase in leukemia for workers exposed to multiple chemicals including ethylene oxide however, in a recent larger Swedish study (249) of workers exposed to only ethylene oxide, there was no association of any type of cancer increase for these workers. In a recent study sponsored by NIOSH, there was no significant increase in mortahty observed for cancer when all types are combined or for certain individual types of cancer, even for those people who worked the longest and were observed the longest. However, a statistically significant increase in mortahty from certain types of lymphoma was observed for male workers. This is contrary to the results observed for female workers. In addition, four other cohort studies of ethylene oxide-exposed workers have been pubhshed (250—253), but no unequivocal increase in the risk of cancer was observed. 

The benefit of a prospective cohort study is the possibility for accurate exposure assessment. However, these are not common, because many occupational diseases (including cancers which are being intensely investigated currently) require long exposure times to develop. It is not practical or ethical to wait for decades before one obtains the result. 

The problems often encountered in retrospective cohort studies include poor exposure data and incomplete follow-up of all individuals. The accuracy of health outcome data may also be low. 

Cohort A group of individuals that share a particular statistical or demographic characteristic, e.g., exposure. 

The two basic types of analytical studies are the cohort and the case-control study. Each has strengths and weaknesses as well as different resource and time requirements. The cohort study involves the study of indi iduals classified by e.xposure characteristics, e.g., a group of welders. The study then follows the development of disease in the welders group as well as in an unexposed comparison population. The measure that assesses the magnitude of... 

Technically, Sex s Carrie Bradshaw and her cohorts were Gen Xers. Sarah Jessica Parker, who played Carrie, is thirty-six. And they all disappeared into commitment and engagement and marriage. 

O Connor PG, Carroll KM, Shi JM, et al Three methods of opioid detoxification in a primary care setting a randomized trial. Ann Intern Med 127 526-530, 1997 Oppenheimer E, Tobutt C, Taylor C, et al Death and survival in a cohort of heroin addicts from London clinics a 22-year follow-up study Addiction 89 1299—1308, 1994... 

Sanchez-Carbonell X, Sens L Ten-year survival analysis of a cohort of heroin addicts in Catalonia the EMETYST project. Addiction 95 941—948, 2000 Schindler SD, Eder H, Ortner R, et al Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 98 103-... 

Degenhardt L, Lynskey MT, Hall W Cohort trends in the age of initiation of drug use in Australia. Aust N Z J Public Health 24 421 26, 2000 Degenhardt L, Hall W, Lynskey MT The relationship between cannabis use, depression and anxiety among Australian adults findings from the National Survey of Mental Health and Well-Being. Soc Psychiatry Psychiatr Epidemiol 36 219— 227, 2001... 

Hurt RD, Offord KP, Croghan IT, et al Mortality following inpatient addictions treatment role of tobacco use in a community-based cohort. JAMA 275 1097—1103, 1996... 

Part (d) of the question in Fig. 8.8 required students to draw a microscopic representation of the contents of the container after the reaction. Just over a quarter of the cohort were able to draw a correct representation of the reaction mixture, namely ammonia and the agent in excess. Almost a fifth of students drew a suitable sub-micro representation of the product molecules but did not include the reagent in excess. About one third of the responses contained a wide variety of incorrect submicro representations. Even though students had been taught stoichiometry using sub-micro diagrams such as Fig. 8.4, a number of them (19%) drew diagrams con-... 

Cohort Study—A type of epidemiological study of a specific group or groups of people who have had a common insult (e.g., exposure to an agent suspected of causing disease or a common disease) and are followed forward from exposure to outcome. At least one exposed group is compared to one unexposed group. 

Prospective Study—A type of cohort study in which the pertinent observations are made on events occurring after the start of the study. A group is followed over time. 

Retrospective Study—A type of cohort study based on a group of persons known to have been exposed at some time in the past. Data are collected from routinely recorded events, up to the time the study is undertaken. Retrospective studies are limited to causal factors that can be ascertained from existing records and/or examining survivors of the cohort. 

Ealagas ME, Paya C, Ruthazer R, Badley A, Patel R, Wiesner R et al. (1998) Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation a prospective derivation and validation cohort analysis. Transplantation 66 1020-1028 Field AK (1999) Human cytomegalovirus challenges, opportunities and new drug development. Antivir Chem Chemother 10 219-232... 

Data from a number of clinical cohort studies and clinical trials iUusfrates that HlV-1 is predominantly classified as R5 in tteatment-naive patients (Brumme et al. 2005 Moyle et al. 2005). In tteatment-experienced patients (with low nadir CD4- -count), there is an increase in CXCR4-using virus, which is almost entirely due to an increase in D/M virus (Moyle et al. 2005 Melby et al. 2006a). Pure X4 virus remains rare and indeed, even in treatment-experienced patients, 47-62% of patients continue to have only R5 virus. 

The choice of IFN-a as a potential treatment for chronic hepatitis C in 1986 was empirical (Hoofnagle et al. 1986). At this time, the causative agent of chronic non-A, non-B hepatitis had not yet been identified, and there was no way of evaluating HCV replication or, thus, the antiviral activity of a drug. In the first cohort of 10 patients with chronic non-A, non-B hepatitis treated with IFN-a, a significant decline in alanine aminotransferase (ALT) levels was observed in 8 patients, and liver histology had improved at the end of therapy in the three patients who were biopsied (Hoofnagle et al. 1986). Ten years later, 5 of the 10 patients were free of infection (Lau et al. 1998). 

In two published cohort studies, pegylated IFN-a was effective in approximately one-third of HBeAg-positive patients in whom standard IFN-a or lamivudine had failed (Flink et al. 2006a Leemans et al. 2006). 

In HBeAg-negative patients, 12 weeks of lamivudine monotherapy followed by 36 months of pegylated lFN-a2b therapy (including 3 months of concomitant administration) has been compared with 48 weeks of lamivudine monotherapy (Vassiliadis et al. 2007). At the end of follow-up, the rate of ALT normalization was significantly higher with the sequential therapy than with lamivudine alone. No difference in the proportion of patients with undetectable HBV DNA was observed. Similar results were obtained in a Chinese cohort study (Shi et al. 2006). 

To compare the epidemiological, clinical, and economic impacts of the HIV epidemic in Italy prior to and after the introduction of HAART, Tramarin et al. (2004) conducted a prospective and observational study with a multi-center design. They used data collected on an AIDS cohort from 1994 and updated data from a comparable cohort in 1998. Mortality and medical costs of 251 patients were measured in 1994 and in 1998, respectively. A considerable difference was observed in mortality (33.9% in 1994 vs. 3.9% in 1998). The cost per patient per year was US 15,515 in 1994 and US 10,312 in 1998. Based on the comparison of the two cohorts between both years, the authors concluded that after the introduction of HAART, hospital-based provision shifted from an inpatient-based to an outpatient-based service, with major focus on pharmaceutical care. 

Stoll et al. (2002b) examined provider costs in a German monocentric cohort of HIV-infected patients after the introduction of HA ART. According to their findings, mean provider costs per capita decreased from US 31,812 in 1997 to US 21,926 in 2001. The costs of HA ART per capita decreased significantly from US 15,739 in 1997 to US 14,336 in 2001. Also quite impressive was the continuous decrease of expenditures for additional drug therapy (-43.3%) and hospitalization (-52.1%), respectively. However, the costs caused by HAART increased from 49.5% of all provider costs in 1997 to 65.4% in 2001. 

Alternatively, some studies used expert opinion to extrapolate the effectiveness of donepezil over a longer period (Neumann et al, 1999 O Brien et al, 1999). However, it is recognized that expert opinion can be the weakest source of evidence, which introduces considerable uncertainty into the analysis and interpretation of the results. In addition, the cost-effectiveness of acetylcholinesterase inhibitors depends heavily on the distribution of the cohort of patients across different severity states. O Brien s team found that the results of their model were very sensitive to this variable. In this context, the correct... 

---